Portal for life science/healthcare startups
  • Home
    • English Top
    • 日本語トップ
  • Table of Contents (English)
    • Business Setup & Operations >
      • Startup Visa
      • setup corporation, office in Japan
      • Company establishment
      • Life Science Hub, Startup Hub
    • Public Support >
      • List of Public Support Organizations
      • Public Support in Yokohama city
      • Academia-Based Startup Support Guide
      • Mediso free consultation service
    • Regulatory & Compliance >
      • PMDA consultation
      • regulatory considerations when using person infformation
      • Guide to Selecting Regulatory Affairs Staff and Consultants
      • Expedited Review Systems for Pharmaceuticals
      • Guidelines for Establishing Generic Drug Names
      • Combination Products, Combination Medical Devices, Kit Products, Combination Drugs
    • Medical Device >
      • DMAH: Designated Marketing Authorization Holder-Summary Ver.
      • DMAH: Designated Marketing Authorization Holder
      • Combination Products, Combination Medical Devices, Kit Products, Kit Components, Assortment Products
      • How to determine if a product is a medical device
      • medical device classification for combined products
      • medical device class
      • how to confirm JMDN of medical device
      • medical device & IVD reimbursement-Summary Ver.
      • medical device & IVD reimbursemenet
      • insurance reimbursement for SaMD
      • Comparison of Medical Device Definitions: Japan, US, & EU
    • Pharmaceutical, regenerative medicine >
      • How to determine if a product is a Pharmaceutical Drug
      • Advanced Medical Care System
      • Over-The-Counter (OTC) Drug
    • Healthcare & Caretech Products >
      • guidance for non medical services
      • Therapeutic Orthoses and Assistive Devices
      • Cosmetics and Quasi-Drugs
    • Funding, Partnering & Networking >
      • Utilization of Public Grants and Subsidies
      • J-Ships
      • Partnering
    • Intellectual Property >
      • patent or trade secret?
      • employee invention
    • Legal & Contracts >
      • References for Contracts
      • Guide to Industry-Academia Collaboration Agreements for Academic Researchers
    • Academia & Tech Transfer
    • Licensing, partnering >
      • Introducing Seeds to Pharmaceutical Companies
    • References in English
  • コンテンツ一覧
    • 事業設立・運営 >
      • 法人設立
      • ライフサイエンスハブ、スタートアップハブ
    • 公的支援 >
      • 公的支援機関リスト
      • 大学発スタートアップ支援機関・プログラムガイド
      • AMED Medical IP Desk
      • MEDISO活用のススメ
    • 薬事・規制関連 >
      • 全般 >
        • PMDA RS相談活用のススメ
        • 薬事スタッフ・コンサル選定ガイド
        • 都道府県薬務課一覧
        • コンビネーション製品、組合せ医療機器、キット製品、組合せ医薬品
      • 医薬品、再生医療等製品 >
        • 医薬品の該当性確認方法
        • 医薬品一般的名称設定のガイドライン
        • 先進医療制度
        • 一般用医薬品(OTC)
      • 医療機器 >
        • 医療機器該当性確認ガイド
        • 医療機器と非医療機器の機能が複合した製品は?
        • 医療機器の一般的名称と確認方法
        • 医療機器のクラス分類
        • 医療機器・体外診の保険収載
        • SaMDの保険収載
    • ヘルスケア・ケアテック >
      • 非医療分野の検査サービスを展開する際に注意すべきポイント
      • 治療用装具と補装具
      • 化粧品及び医薬部外品
    • 資金調達 >
      • 公的な助成金、補助金の活用
      • 特定投資家向け銘柄制度(J-Ships)
      • パートナリング
    • 知的財産 >
      • 特許か?営業秘密か?
      • 職務発明:アカデミア・公的研究機関に所属する研究者が注意すべきポ
    • 法務・契約 >
      • 契約関連で参考になる公的機関の資料
      • 個人情報を利用する製品開発時の 留意すべき法規制
    • アカデミア、技術移転 >
      • アカデミア研究者のための産学連携契約ガイド
    • ライセンシング、パートナリング >
      • 製薬企業等へのシーズ紹介
    • 海外展開 >
      • 公的機関の海外展開支援
      • 横浜市の公的支援サービス
      • JETROを徹底活用しよう
      • 日米欧での医療機器定義の比較
      • 簡略審査(審査の迅速化)
      • 海外規制等の情報収集
    • オーストラリア >
      • オーストラリア研究開発優遇税制の概要
      • オーストラリア研究開発優遇税制の適用を受けるには
      • オーストラリアでの主要イベント
      • R&D関連の公的機関
      • オーストラリア助成金情報

DMAH: Designated Marketing Authorization Holder-Summary Ver.
​

​ ​-The most efficient entry pathway for foreign medical device & IVD firms

*Please note that the majority of references are in Japanese. This is due to accuracy and a significant lack of official documents available in English.
*Communication with regulatory authorities and other organizations is mostly in Japanese. Also, given the subtle nuances and business customs that are hard for non-Japanese to grasp, I recommend you to secure a Japanese person (even on a part-time or contract basis).
The Most Advantageous Market Entry Route
  • Among the three main routes, the "Foreign Special Approval System" using a DMAH is the most strategically advantageous option.
​
Why?
  • It allows overseas manufacturers to secure the product's marketing approval for themselves
  • This is possible without establishing a legal entity in Japan.
  • Complex domestic regulatory affairs are outsourced to a specialized company (the DMAH).
  • This is considered the most rational and superior route for many overseas manufacturers.


What is the DMAH System?
  • Foreign Special Approval System:
    • A system that allows overseas medical device manufacturers without a business office in Japan to enter the market while holding the product approval themselves
    • https://www.pmda.go.jp/review-services/drug-reviews/foreign-mfr/0008.html 
 
  • Designated Marketing Authorization Holder (DMAH):
    • When using this system, it is legally required to designate a DMAH. 
    • The DMAH must hold a Marketing Authorization Holder license. 
    • They are the entity responsible for all regulatory duties within Japan.


DMAH Responsibilities
The DMAH assumes full responsibility within Japan on behalf of the overseas manufacturer, including: 
  • Carrying out procedures for obtaining product marketing approval
  • Performing quality control (QMS) after approval
  • Performing post-market safety management (GVP)
  • Serving as the official liaison with regulatory authorities (like the PMDA)


Key Distinction: DMAH vs. MAH
The owner of the product approval is different:
  • General MAH (Marketing Authorization Holder):
    • The MAH is the owner of the product's marketing approval.
  • DMAH Model (Foreign Special Approval System):
    • The DMAH is not the owner of the product approval. 
    • The overseas manufacturer is the owner of the marketing approval.


Advantages of the DMAH Model
  • Maintain Market Control: The overseas manufacturer holds the product approval, which is the greatest advantage.
  • Flexible Sales Strategy: Approval is not tied to a specific sales partner, allowing you to appoint multiple distributors or change them freely.
  • Reduced Cost & Time: Initial investment is significantly reduced compared to establishing a Japanese subsidiary, enabling faster market entry.

Disadvantages of Distributor as MAH Model
  • The Risk: The distributor holds the product approval.
  • Loss of Control: The manufacturer becomes dependent on the distributor.
  • Switching Barriers: If you want to change distributors, you may restart the regulatory process from scratch with the new partner, costing time and money.

Disadvantages of Japanese Subsidiary Model
  • This model requires enormous initial costs and time for
    • Establishing the company and office
    • Hiring specialized personnel required by the PMD Act
    • Obtaining the Marketing Authorization Holder license
    • The subsidiary must also be responsible for all product quality and safety post-market (in case of being MAH itself). 
  • This is an extremely high barrier to entry, especially for SMEs and startups.


Key Steps Related to DMAH
  • Select a DMAH Partner
    • This is the first and primary thing to do.
    • All applications to Japanese regulatory authorities must go through a licensed domestic entity, so you must select a DMAH and conclude a contract first.
  • Foreign Manufacturer Establishment Registration (FMER)
    • Before the product approval application, the overseas manufacturing facility must be registered with the MHLW.
    • The DMAH usually handles this application on the manufacturer's behalf.

Key Criteria for Selecting a DMAH (1/2)
  • Type and Scope of License:
    • Confirm the DMAH's license matches your product's classification.
      • Type 1: Class III & IV
      • Type 2: Class II
      • Type 3: Class I
  • Experience and Expertise:
    • Check their track record with similar devices.
    • Verify they have experience negotiating with the PMDA.
    • Experience collaborating with overseas manufacturers is particularly important.

Key Criteria for Selecting a DMAH (2/2)
  • Personnel Structure:
    • Verify they have qualified personnel for the "Three Roles" (San-yaku) required by the PMD Act.
  • Communication Ability:
    • Assess their system for reporting and coordinating smoothly in foreign languages (e.g., English).
  • Transparency of Fee Structure:
    • Confirm the fee structure is clear.
    • Monthly fixed costs (retainer fees) and variable costs (for applications, etc.) should be clearly distinguished.


Recommended Actions for Market Entry
  1. Basic Understanding: Gather information on Japanese laws and regulations.
  2. Confirm Product Class: Check your product's applicability and classification as a medical device/IVD roughly.
  3. Select DMAH: Use web searches, events like Bio
  4. Select Distributor (as needed): It is advisable to leverage the DMAH's network.


Others
  • Special Case: Outsourcing to a Japanese Manufacturer
    • This applies if an overseas company outsources manufacturing to a domestic Japanese manufacturer.
    • The Japanese manufacturer requires a "Manufacturing License".
    • The QMS conformity assessment applies to the Japanese facility, not the overseas one.
    • A documented quality agreement between the DMAH and the domestic manufacturer is mandatory.
    • Consult with the DMAH first, about the appropriate scheme.​

​@K.Kamitani
Categorization of DMAH by backbone business
Home
About JPRO
Table of Contents
​
​オフィス概要
​コンテンツ一覧
JPRO is a Japan-based business incubator for startups. 
​
Our approach is unique because our primary focus is on enabling startup self-sufficiency. Our core mission is to help startups optimize their time and cost-efficiency, ensuring they avoid unnecessary expenses and delays. We achieve this by providing centralized access to essential, high quality information—all completely free of charge.
​
The reliability of our content is exceptionally high, as our information is sourced directly from public institutions and the advice mirrors what we provide in our official advisory roles within these very organizations.
​"You'll likely gain a clear understanding of what needs to be done, enabling you to manage many aspects of your business in-house."
  • Home
    • English Top
    • 日本語トップ
  • Table of Contents (English)
    • Business Setup & Operations >
      • Startup Visa
      • setup corporation, office in Japan
      • Company establishment
      • Life Science Hub, Startup Hub
    • Public Support >
      • List of Public Support Organizations
      • Public Support in Yokohama city
      • Academia-Based Startup Support Guide
      • Mediso free consultation service
    • Regulatory & Compliance >
      • PMDA consultation
      • regulatory considerations when using person infformation
      • Guide to Selecting Regulatory Affairs Staff and Consultants
      • Expedited Review Systems for Pharmaceuticals
      • Guidelines for Establishing Generic Drug Names
      • Combination Products, Combination Medical Devices, Kit Products, Combination Drugs
    • Medical Device >
      • DMAH: Designated Marketing Authorization Holder-Summary Ver.
      • DMAH: Designated Marketing Authorization Holder
      • Combination Products, Combination Medical Devices, Kit Products, Kit Components, Assortment Products
      • How to determine if a product is a medical device
      • medical device classification for combined products
      • medical device class
      • how to confirm JMDN of medical device
      • medical device & IVD reimbursement-Summary Ver.
      • medical device & IVD reimbursemenet
      • insurance reimbursement for SaMD
      • Comparison of Medical Device Definitions: Japan, US, & EU
    • Pharmaceutical, regenerative medicine >
      • How to determine if a product is a Pharmaceutical Drug
      • Advanced Medical Care System
      • Over-The-Counter (OTC) Drug
    • Healthcare & Caretech Products >
      • guidance for non medical services
      • Therapeutic Orthoses and Assistive Devices
      • Cosmetics and Quasi-Drugs
    • Funding, Partnering & Networking >
      • Utilization of Public Grants and Subsidies
      • J-Ships
      • Partnering
    • Intellectual Property >
      • patent or trade secret?
      • employee invention
    • Legal & Contracts >
      • References for Contracts
      • Guide to Industry-Academia Collaboration Agreements for Academic Researchers
    • Academia & Tech Transfer
    • Licensing, partnering >
      • Introducing Seeds to Pharmaceutical Companies
    • References in English
  • コンテンツ一覧
    • 事業設立・運営 >
      • 法人設立
      • ライフサイエンスハブ、スタートアップハブ
    • 公的支援 >
      • 公的支援機関リスト
      • 大学発スタートアップ支援機関・プログラムガイド
      • AMED Medical IP Desk
      • MEDISO活用のススメ
    • 薬事・規制関連 >
      • 全般 >
        • PMDA RS相談活用のススメ
        • 薬事スタッフ・コンサル選定ガイド
        • 都道府県薬務課一覧
        • コンビネーション製品、組合せ医療機器、キット製品、組合せ医薬品
      • 医薬品、再生医療等製品 >
        • 医薬品の該当性確認方法
        • 医薬品一般的名称設定のガイドライン
        • 先進医療制度
        • 一般用医薬品(OTC)
      • 医療機器 >
        • 医療機器該当性確認ガイド
        • 医療機器と非医療機器の機能が複合した製品は?
        • 医療機器の一般的名称と確認方法
        • 医療機器のクラス分類
        • 医療機器・体外診の保険収載
        • SaMDの保険収載
    • ヘルスケア・ケアテック >
      • 非医療分野の検査サービスを展開する際に注意すべきポイント
      • 治療用装具と補装具
      • 化粧品及び医薬部外品
    • 資金調達 >
      • 公的な助成金、補助金の活用
      • 特定投資家向け銘柄制度(J-Ships)
      • パートナリング
    • 知的財産 >
      • 特許か?営業秘密か?
      • 職務発明:アカデミア・公的研究機関に所属する研究者が注意すべきポ
    • 法務・契約 >
      • 契約関連で参考になる公的機関の資料
      • 個人情報を利用する製品開発時の 留意すべき法規制
    • アカデミア、技術移転 >
      • アカデミア研究者のための産学連携契約ガイド
    • ライセンシング、パートナリング >
      • 製薬企業等へのシーズ紹介
    • 海外展開 >
      • 公的機関の海外展開支援
      • 横浜市の公的支援サービス
      • JETROを徹底活用しよう
      • 日米欧での医療機器定義の比較
      • 簡略審査(審査の迅速化)
      • 海外規制等の情報収集
    • オーストラリア >
      • オーストラリア研究開発優遇税制の概要
      • オーストラリア研究開発優遇税制の適用を受けるには
      • オーストラリアでの主要イベント
      • R&D関連の公的機関
      • オーストラリア助成金情報